Effect of Predefined Homoeopathic Medicines in Cervical Spondylosis Pain Management.

A multi centre randomized double blind placebo controlled clinical trial of Predefined Homoeopathic Medicines in Cervical Spondylosis Pain Management

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/12/002270

Enrollment

140

Registered

2011-12-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pain due to Cervical spondylosis

Interventions

Intervention1: Predefined Homoeopathic medicines List of trial medicines: 1. Paris quadrifolia 2. Calcarea carb. 3. Gelsemium 4. Cocculus indicus 5. Cimicifuga 6. Rhus toxicodendron 7. Causticum 8

Eligibility

Inclusion criteria

Inclusion criteria: ? Patients with chief complaint of neck pain including pain in suboccipital and interscapular region within 2 weeks. ? One or more episodes of neck pain, neck stiffness attack on average per month for at least 3 months. ? Positive radiological findings for cervical spondylosis. ? VAS score for pain is minimum 4. ? Patient not on anti inflammatory or other therapy in the past 1week known to affect the study outcome.

Exclusion criteria

Exclusion criteria: ? Cervical myelopathy or radiculopathy. ? Patient with neck pain and normal x-ray Cervical spine. ? Patients on physiotherapy. ? Having neck trauma/ fracture/ surgery history/ congenital spinal abnormalities. ? Any systemic diseases of bones and joints. ? Other non-specific neck pain lesions?acute neck strain, postural neck ache, or whiplash. ? Suffering from any systemic diseases such as hypertension, diabetes mellitus, Cardio/ Cerebro-vascular diseases etc. ? Inability to comply with the study protocol, alcoholics, drug users including psychiatric diseases. ? Pregnant and lactating women. ? Patients deemed ineligible by the investigators. ? Patient unwilling to sign the written informed consent form.

Design outcomes

Primary

Measure	Time frame
Visual Analogue ScaleTimepoint: Assessment of pain from Visual analogue scale shall be done daily for 7 days	—

Secondary

Measure	Time frame
? To assess the changes in CSPMS. ? To assess the rating of Patient and Clinical Global Impression (CGI) scale. Timepoint: CSPMS and Assessment of the quality of life of patients with Patient and Clinical Global Impression (CGI) scale shall be filled up on the 3rd and 8th day of the study period.	—

Countries

India

Contacts

Public ContactDr Jaya Gupta

Central Council for Research in Homoeopathy

jgupta21@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026